MAP2K1 and small cell lung carcinoma: 36455195 36455195 Cheng ML, Lee JK, Kumar R et al (2022) Response to MEK Inhibitor Therapy in MAP2K1 (MEK1) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of MAP2K1 Mutations in Non-Small-Cell Lung Cancer.